HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5-hydroxyisourate

an intermediate in the degradation of uric acid to allantoin; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Xanthines: 123
    - Uric Acid: 17354
      - 5-hydroxyisourate: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purinones: 2
        Xanthines: 123
        Uric Acid: 17354
        5-hydroxyisourate: 1

Experts

1.	Alexander, Warren S: 1 article (09/2010)
2.	Bahlo, Melanie: 1 article (09/2010)
3.	Gill, Anthony: 1 article (09/2010)
4.	Hennebry, Sarah: 1 article (09/2010)
5.	Hilton, Adrienne A: 1 article (09/2010)
6.	Hilton, Douglas J: 1 article (09/2010)
7.	Hyland, Craig D: 1 article (09/2010)
8.	Masters, Seth L: 1 article (09/2010)
9.	Metcalf, Donald: 1 article (09/2010)
10.	Morgan, Phillip O: 1 article (09/2010)

Related Diseases

1.	Hepatomegaly 09/21/2010 - "Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice."
2.	Hepatocellular Carcinoma (Hepatoma) 09/21/2010 - "Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice."

Related Drugs and Biologics

1.	Hydrolases